Abstract
One of the major obstacles to effective prolonged CD8 T cell control over HIV and other latent infections may be the intrinsic, genetically programmed barrier to unlimited proliferation that is characteristic of all normal human somatic cells. Replicative senescence, characterized extensively in cell culture for a variety of cell types, comprises both irreversible cell cycle arrest and striking changes in function. CD8 T cells with features similar to senescent CD8 T cell cultures (i.e., absence of CD28, inability to proliferate, telomeres in the 5-7 kb range, resistance to apoptosis) increase progressively during aging and in chronic HIV infection, suggesting that replicative senescence may be occurring in vivo, and, in fact, may constitute the final stage in the normal differentiation of human T cells. CD8 T cells with characteristics suggestive of senescence have also been implicated in modulating immune function and altering bone homeostasis. Further characterization of the underlying mechanism leading to the generation of senescent memory CD8 T cells and analysis of their functional attributes will help elucidate their role in HIV disease pathogenesis.
Keywords: Replicative senescence,, CD8 T cells,, HIV,, aging.
Current HIV Research
Title: Replicative Senescence: The Final Stage of Memory T Cell Differentiation?
Volume: 1 Issue: 2
Author(s): Rita B. Effros
Affiliation:
Keywords: Replicative senescence,, CD8 T cells,, HIV,, aging.
Abstract: One of the major obstacles to effective prolonged CD8 T cell control over HIV and other latent infections may be the intrinsic, genetically programmed barrier to unlimited proliferation that is characteristic of all normal human somatic cells. Replicative senescence, characterized extensively in cell culture for a variety of cell types, comprises both irreversible cell cycle arrest and striking changes in function. CD8 T cells with features similar to senescent CD8 T cell cultures (i.e., absence of CD28, inability to proliferate, telomeres in the 5-7 kb range, resistance to apoptosis) increase progressively during aging and in chronic HIV infection, suggesting that replicative senescence may be occurring in vivo, and, in fact, may constitute the final stage in the normal differentiation of human T cells. CD8 T cells with characteristics suggestive of senescence have also been implicated in modulating immune function and altering bone homeostasis. Further characterization of the underlying mechanism leading to the generation of senescent memory CD8 T cells and analysis of their functional attributes will help elucidate their role in HIV disease pathogenesis.
Export Options
About this article
Cite this article as:
Effros B. Rita, Replicative Senescence: The Final Stage of Memory T Cell Differentiation?, Current HIV Research 2003; 1 (2) . https://dx.doi.org/10.2174/1570162033485348
DOI https://dx.doi.org/10.2174/1570162033485348 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Incorporation of Targeted Agents in the Management of Patients with Advanced Gastric Cancer
Current Medicinal Chemistry Anti-Cancer Cytotoxic Effects of Multiwalled Carbon Nanotubes
Current Pharmaceutical Design Modified Envelope Glycoproteins to Retarget Retroviral Vectors
Current Gene Therapy Recent Clinical Advances in the Treatment of Cutaneous Melanoma
Clinical Cancer Drugs Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer
Current Protein & Peptide Science Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview
Mini-Reviews in Medicinal Chemistry Mitochondrial genome sequencing in atherosclerosis: what's next?
Current Pharmaceutical Design TRP Channels as A Newly Emerging Non-Voltage-Gated Ca2+ Entry Channel Superfamily
Current Pharmaceutical Design Targeting Mutant KRAS for Anticancer Therapy
Current Topics in Medicinal Chemistry Onconeural Versus Paraneoplastic Antigens?
Current Medicinal Chemistry Cellular Based Cancer Vaccines: Type 1 Polarization of Dendritic Cells
Current Medicinal Chemistry Approaches for the Inhibition of Human Telomerase Based on the Use of Peptide Nucleic Acids and Hammerhead Ribozymes
Mini-Reviews in Medicinal Chemistry Advances in Drug Safety
Current Pharmaceutical Design Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis
Current Pharmaceutical Design The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Current Drug Discovery Technologies Targeting Ion Channels in Leukemias: A New Challenge for Treatment
Current Medicinal Chemistry Neuropeptides as Autocrine Growth Factors in Cancer Cells
Current Pharmaceutical Design A Review of Nutrition Education: Before, Between and Beyond Pregnancy
Current Women`s Health Reviews Curcumin Exposure Modulates Multiple Pro-Apoptotic and Anti-Apoptotic Signaling Pathways to Antagonize Acetaminophen-Induced Toxicity
Current Neurovascular Research Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis
Current Cancer Drug Targets